JPMORGAN CHASE & CO - ELEDON PHARMACEUTICALS INC ownership

ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ELEDON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$3626
+30.0%
0.00%
Q3 2021$0
-100.0%
20
-69.7%
0.00%
Q2 2021$1,000660.00%
Other shareholders
ELEDON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Logos Global Management LP 1,339,793$8,280,0000.60%
CM Management, LLC 75,000$464,0000.35%
BVF INC/IL 1,363,435$8,426,0000.33%
Cormorant Asset Management, LP 1,305,095$8,065,0000.33%
Ikarian Capital, LLC 344,578$2,129,0000.15%
Woodline Partners LP 781,376$4,829,0000.08%
Eversept Partners, LP 114,008$704,5690.05%
INGALLS & SNYDER LLC 51,149$316,0000.01%
Virtu Financial LLC 18,610$115,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 34,630$214,0000.01%
View complete list of ELEDON PHARMACEUTICALS INC shareholders